nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Niacin—atherosclerosis	0.109	0.169	CbGbCtD
Oxymorphone—CYP2D6—Simvastatin—atherosclerosis	0.0862	0.134	CbGbCtD
Oxymorphone—CYP2D6—Lovastatin—atherosclerosis	0.0844	0.131	CbGbCtD
Oxymorphone—CYP2D6—Pravastatin—atherosclerosis	0.0844	0.131	CbGbCtD
Oxymorphone—CYP3A4—Ezetimibe—atherosclerosis	0.059	0.0916	CbGbCtD
Oxymorphone—CYP3A4—Rosuvastatin—atherosclerosis	0.059	0.0916	CbGbCtD
Oxymorphone—CYP3A4—Simvastatin—atherosclerosis	0.0548	0.0851	CbGbCtD
Oxymorphone—CYP3A4—Pravastatin—atherosclerosis	0.0537	0.0833	CbGbCtD
Oxymorphone—CYP3A4—Lovastatin—atherosclerosis	0.0537	0.0833	CbGbCtD
Oxymorphone—Memory impairment—Rosuvastatin—atherosclerosis	0.00438	0.0178	CcSEcCtD
Oxymorphone—Naloxone—TLR4—atherosclerosis	0.00416	0.711	CrCbGaD
Oxymorphone—Laryngeal oedema—Niacin—atherosclerosis	0.0039	0.0159	CcSEcCtD
Oxymorphone—Memory impairment—Lovastatin—atherosclerosis	0.00371	0.0151	CcSEcCtD
Oxymorphone—Drug interaction—Rosuvastatin—atherosclerosis	0.00371	0.0151	CcSEcCtD
Oxymorphone—Memory impairment—Ezetimibe—atherosclerosis	0.00364	0.0148	CcSEcCtD
Oxymorphone—Lung disorder—Niacin—atherosclerosis	0.00354	0.0144	CcSEcCtD
Oxymorphone—Memory impairment—Simvastatin—atherosclerosis	0.00347	0.0141	CcSEcCtD
Oxymorphone—Laryngospasm—Niacin—atherosclerosis	0.00335	0.0136	CcSEcCtD
Oxymorphone—Memory impairment—Pravastatin—atherosclerosis	0.00314	0.0128	CcSEcCtD
Oxymorphone—Drug interaction—Ezetimibe—atherosclerosis	0.00308	0.0125	CcSEcCtD
Oxymorphone—Drug interaction—Simvastatin—atherosclerosis	0.00294	0.012	CcSEcCtD
Oxymorphone—Amnesia—Rosuvastatin—atherosclerosis	0.00266	0.0108	CcSEcCtD
Oxymorphone—Drug interaction—Pravastatin—atherosclerosis	0.00266	0.0108	CcSEcCtD
Oxymorphone—Amnesia—Lovastatin—atherosclerosis	0.00225	0.00916	CcSEcCtD
Oxymorphone—Hot flush—Ezetimibe—atherosclerosis	0.00222	0.00902	CcSEcCtD
Oxymorphone—Amnesia—Ezetimibe—atherosclerosis	0.00221	0.00898	CcSEcCtD
Oxymorphone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.0022	0.00894	CcSEcCtD
Oxymorphone—Amnesia—Simvastatin—atherosclerosis	0.00211	0.00856	CcSEcCtD
Oxymorphone—Hot flush—Pravastatin—atherosclerosis	0.00191	0.00778	CcSEcCtD
Oxymorphone—Amnesia—Pravastatin—atherosclerosis	0.0019	0.00774	CcSEcCtD
Oxymorphone—Menopausal symptoms—Pravastatin—atherosclerosis	0.0019	0.00771	CcSEcCtD
Oxymorphone—Diplopia—Pravastatin—atherosclerosis	0.00179	0.00728	CcSEcCtD
Oxymorphone—Urinary retention—Niacin—atherosclerosis	0.00173	0.00703	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Niacin—atherosclerosis	0.00166	0.00675	CcSEcCtD
Oxymorphone—Abdominal distension—Niacin—atherosclerosis	0.00158	0.00643	CcSEcCtD
Oxymorphone—Abdominal distension—Pravastatin—atherosclerosis	0.00156	0.00633	CcSEcCtD
Oxymorphone—Mental disorder—Rosuvastatin—atherosclerosis	0.00151	0.00615	CcSEcCtD
Oxymorphone—Sweating increased—Pravastatin—atherosclerosis	0.00151	0.00613	CcSEcCtD
Oxymorphone—Flatulence—Rosuvastatin—atherosclerosis	0.00148	0.00602	CcSEcCtD
Oxymorphone—Weight decreased—Pravastatin—atherosclerosis	0.0014	0.00569	CcSEcCtD
Oxymorphone—Flushing—Lovastatin—atherosclerosis	0.00136	0.00552	CcSEcCtD
Oxymorphone—Flushing—Ezetimibe—atherosclerosis	0.00133	0.00542	CcSEcCtD
Oxymorphone—Angiopathy—Ezetimibe—atherosclerosis	0.0013	0.0053	CcSEcCtD
Oxymorphone—Immune system disorder—Ezetimibe—atherosclerosis	0.0013	0.00527	CcSEcCtD
Oxymorphone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00129	0.00526	CcSEcCtD
Oxymorphone—Flushing—Simvastatin—atherosclerosis	0.00127	0.00517	CcSEcCtD
Oxymorphone—Mental disorder—Ezetimibe—atherosclerosis	0.00126	0.00511	CcSEcCtD
Oxymorphone—Flatulence—Lovastatin—atherosclerosis	0.00126	0.00511	CcSEcCtD
Oxymorphone—Malnutrition—Ezetimibe—atherosclerosis	0.00125	0.00508	CcSEcCtD
Oxymorphone—Confusional state—Rosuvastatin—atherosclerosis	0.00124	0.00503	CcSEcCtD
Oxymorphone—Flatulence—Ezetimibe—atherosclerosis	0.00123	0.00501	CcSEcCtD
Oxymorphone—Visual impairment—Niacin—atherosclerosis	0.00121	0.00493	CcSEcCtD
Oxymorphone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0012	0.00489	CcSEcCtD
Oxymorphone—Vision blurred—Lovastatin—atherosclerosis	0.0012	0.00488	CcSEcCtD
Oxymorphone—Mental disorder—Simvastatin—atherosclerosis	0.0012	0.00488	CcSEcCtD
Oxymorphone—Visual impairment—Pravastatin—atherosclerosis	0.00119	0.00485	CcSEcCtD
Oxymorphone—Eye disorder—Niacin—atherosclerosis	0.00117	0.00478	CcSEcCtD
Oxymorphone—Flatulence—Simvastatin—atherosclerosis	0.00117	0.00478	CcSEcCtD
Oxymorphone—Naloxone—ESR1—atherosclerosis	0.00117	0.2	CrCbGaD
Oxymorphone—Flushing—Niacin—atherosclerosis	0.00117	0.00474	CcSEcCtD
Oxymorphone—Flushing—Pravastatin—atherosclerosis	0.00115	0.00467	CcSEcCtD
Oxymorphone—Cardiac disorder—Pravastatin—atherosclerosis	0.00115	0.00467	CcSEcCtD
Oxymorphone—Vertigo—Lovastatin—atherosclerosis	0.00114	0.00465	CcSEcCtD
Oxymorphone—Angiopathy—Niacin—atherosclerosis	0.00114	0.00464	CcSEcCtD
Oxymorphone—Vision blurred—Simvastatin—atherosclerosis	0.00112	0.00457	CcSEcCtD
Oxymorphone—Insomnia—Rosuvastatin—atherosclerosis	0.00111	0.00451	CcSEcCtD
Oxymorphone—Palpitations—Ezetimibe—atherosclerosis	0.0011	0.00449	CcSEcCtD
Oxymorphone—Malnutrition—Niacin—atherosclerosis	0.00109	0.00445	CcSEcCtD
Oxymorphone—Chest pain—Lovastatin—atherosclerosis	0.00108	0.00441	CcSEcCtD
Oxymorphone—Anxiety—Lovastatin—atherosclerosis	0.00108	0.0044	CcSEcCtD
Oxymorphone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00108	0.00439	CcSEcCtD
Oxymorphone—Hypertension—Ezetimibe—atherosclerosis	0.00108	0.00439	CcSEcCtD
Oxymorphone—Flatulence—Niacin—atherosclerosis	0.00108	0.00438	CcSEcCtD
Oxymorphone—Tension—Niacin—atherosclerosis	0.00107	0.00437	CcSEcCtD
Oxymorphone—Vertigo—Simvastatin—atherosclerosis	0.00107	0.00435	CcSEcCtD
Oxymorphone—Chest pain—Ezetimibe—atherosclerosis	0.00106	0.00433	CcSEcCtD
Oxymorphone—Nervousness—Niacin—atherosclerosis	0.00106	0.00432	CcSEcCtD
Oxymorphone—Flatulence—Pravastatin—atherosclerosis	0.00106	0.00432	CcSEcCtD
Oxymorphone—Dry mouth—Lovastatin—atherosclerosis	0.00106	0.00431	CcSEcCtD
Oxymorphone—Tension—Pravastatin—atherosclerosis	0.00106	0.0043	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00106	0.0043	CcSEcCtD
Oxymorphone—Pain—Rosuvastatin—atherosclerosis	0.00105	0.00427	CcSEcCtD
Oxymorphone—Constipation—Rosuvastatin—atherosclerosis	0.00105	0.00427	CcSEcCtD
Oxymorphone—Confusional state—Lovastatin—atherosclerosis	0.00105	0.00426	CcSEcCtD
Oxymorphone—Nervousness—Pravastatin—atherosclerosis	0.00105	0.00426	CcSEcCtD
Oxymorphone—Dry mouth—Ezetimibe—atherosclerosis	0.00104	0.00423	CcSEcCtD
Oxymorphone—Vision blurred—Niacin—atherosclerosis	0.00103	0.00419	CcSEcCtD
Oxymorphone—Confusional state—Ezetimibe—atherosclerosis	0.00103	0.00418	CcSEcCtD
Oxymorphone—Vision blurred—Pravastatin—atherosclerosis	0.00102	0.00413	CcSEcCtD
Oxymorphone—Chest pain—Simvastatin—atherosclerosis	0.00101	0.00413	CcSEcCtD
Oxymorphone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00101	0.00411	CcSEcCtD
Oxymorphone—Anxiety—Simvastatin—atherosclerosis	0.00101	0.00411	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.001	0.00408	CcSEcCtD
Oxymorphone—Nervous system disorder—Ezetimibe—atherosclerosis	0.001	0.00407	CcSEcCtD
Oxymorphone—Anorexia—Lovastatin—atherosclerosis	0.000991	0.00403	CcSEcCtD
Oxymorphone—Skin disorder—Ezetimibe—atherosclerosis	0.000991	0.00403	CcSEcCtD
Oxymorphone—Vertigo—Niacin—atherosclerosis	0.000983	0.004	CcSEcCtD
Oxymorphone—Syncope—Niacin—atherosclerosis	0.000981	0.00399	CcSEcCtD
Oxymorphone—Confusional state—Simvastatin—atherosclerosis	0.000981	0.00399	CcSEcCtD
Oxymorphone—Urticaria—Rosuvastatin—atherosclerosis	0.000975	0.00396	CcSEcCtD
Oxymorphone—Oedema—Simvastatin—atherosclerosis	0.000973	0.00396	CcSEcCtD
Oxymorphone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00097	0.00394	CcSEcCtD
Oxymorphone—Vertigo—Pravastatin—atherosclerosis	0.000968	0.00394	CcSEcCtD
Oxymorphone—Palpitations—Niacin—atherosclerosis	0.000967	0.00393	CcSEcCtD
Oxymorphone—Loss of consciousness—Niacin—atherosclerosis	0.000962	0.00391	CcSEcCtD
Oxymorphone—Insomnia—Lovastatin—atherosclerosis	0.000941	0.00382	CcSEcCtD
Oxymorphone—Hypertension—Pravastatin—atherosclerosis	0.00093	0.00378	CcSEcCtD
Oxymorphone—Anorexia—Simvastatin—atherosclerosis	0.000927	0.00377	CcSEcCtD
Oxymorphone—Dyspnoea—Lovastatin—atherosclerosis	0.000927	0.00377	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000925	0.00376	CcSEcCtD
Oxymorphone—Insomnia—Ezetimibe—atherosclerosis	0.000923	0.00375	CcSEcCtD
Oxymorphone—Chest pain—Pravastatin—atherosclerosis	0.000917	0.00373	CcSEcCtD
Oxymorphone—Dyspepsia—Lovastatin—atherosclerosis	0.000915	0.00372	CcSEcCtD
Oxymorphone—Anxiety—Pravastatin—atherosclerosis	0.000914	0.00372	CcSEcCtD
Oxymorphone—Dry mouth—Niacin—atherosclerosis	0.000911	0.0037	CcSEcCtD
Oxymorphone—Dyspnoea—Ezetimibe—atherosclerosis	0.000909	0.0037	CcSEcCtD
Oxymorphone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000904	0.00368	CcSEcCtD
Oxymorphone—Decreased appetite—Lovastatin—atherosclerosis	0.000904	0.00368	CcSEcCtD
Oxymorphone—Dyspepsia—Ezetimibe—atherosclerosis	0.000898	0.00365	CcSEcCtD
Oxymorphone—Fatigue—Lovastatin—atherosclerosis	0.000897	0.00365	CcSEcCtD
Oxymorphone—Oedema—Niacin—atherosclerosis	0.000893	0.00363	CcSEcCtD
Oxymorphone—Pain—Lovastatin—atherosclerosis	0.000889	0.00362	CcSEcCtD
Oxymorphone—Constipation—Lovastatin—atherosclerosis	0.000889	0.00362	CcSEcCtD
Oxymorphone—Confusional state—Pravastatin—atherosclerosis	0.000887	0.00361	CcSEcCtD
Oxymorphone—Decreased appetite—Ezetimibe—atherosclerosis	0.000887	0.00361	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000881	0.00358	CcSEcCtD
Oxymorphone—Asthenia—Rosuvastatin—atherosclerosis	0.00088	0.00358	CcSEcCtD
Oxymorphone—Insomnia—Simvastatin—atherosclerosis	0.00088	0.00358	CcSEcCtD
Oxymorphone—Oedema—Pravastatin—atherosclerosis	0.000879	0.00358	CcSEcCtD
Oxymorphone—Fatigue—Ezetimibe—atherosclerosis	0.000879	0.00358	CcSEcCtD
Oxymorphone—Shock—Niacin—atherosclerosis	0.000879	0.00357	CcSEcCtD
Oxymorphone—Constipation—Ezetimibe—atherosclerosis	0.000872	0.00355	CcSEcCtD
Oxymorphone—Pain—Ezetimibe—atherosclerosis	0.000872	0.00355	CcSEcCtD
Oxymorphone—Tachycardia—Niacin—atherosclerosis	0.000872	0.00354	CcSEcCtD
Oxymorphone—Pruritus—Rosuvastatin—atherosclerosis	0.000868	0.00353	CcSEcCtD
Oxymorphone—Skin disorder—Niacin—atherosclerosis	0.000868	0.00353	CcSEcCtD
Oxymorphone—Dyspnoea—Simvastatin—atherosclerosis	0.000867	0.00353	CcSEcCtD
Oxymorphone—Hyperhidrosis—Niacin—atherosclerosis	0.000863	0.00351	CcSEcCtD
Oxymorphone—Feeling abnormal—Lovastatin—atherosclerosis	0.000857	0.00348	CcSEcCtD
Oxymorphone—Dyspepsia—Simvastatin—atherosclerosis	0.000856	0.00348	CcSEcCtD
Oxymorphone—Anorexia—Niacin—atherosclerosis	0.000851	0.00346	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00085	0.00346	CcSEcCtD
Oxymorphone—Hyperhidrosis—Pravastatin—atherosclerosis	0.00085	0.00346	CcSEcCtD
Oxymorphone—Decreased appetite—Simvastatin—atherosclerosis	0.000846	0.00344	CcSEcCtD
Oxymorphone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000841	0.00342	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00084	0.00341	CcSEcCtD
Oxymorphone—Diarrhoea—Rosuvastatin—atherosclerosis	0.00084	0.00341	CcSEcCtD
Oxymorphone—Fatigue—Simvastatin—atherosclerosis	0.000839	0.00341	CcSEcCtD
Oxymorphone—Anorexia—Pravastatin—atherosclerosis	0.000838	0.00341	CcSEcCtD
Oxymorphone—Hypotension—Niacin—atherosclerosis	0.000835	0.00339	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000834	0.00339	CcSEcCtD
Oxymorphone—Pain—Simvastatin—atherosclerosis	0.000832	0.00338	CcSEcCtD
Oxymorphone—Constipation—Simvastatin—atherosclerosis	0.000832	0.00338	CcSEcCtD
Oxymorphone—Urticaria—Lovastatin—atherosclerosis	0.000826	0.00336	CcSEcCtD
Oxymorphone—Body temperature increased—Lovastatin—atherosclerosis	0.000822	0.00334	CcSEcCtD
Oxymorphone—Abdominal pain—Lovastatin—atherosclerosis	0.000822	0.00334	CcSEcCtD
Oxymorphone—Dizziness—Rosuvastatin—atherosclerosis	0.000811	0.0033	CcSEcCtD
Oxymorphone—Urticaria—Ezetimibe—atherosclerosis	0.00081	0.00329	CcSEcCtD
Oxymorphone—Insomnia—Niacin—atherosclerosis	0.000808	0.00328	CcSEcCtD
Oxymorphone—Abdominal pain—Ezetimibe—atherosclerosis	0.000806	0.00328	CcSEcCtD
Oxymorphone—Body temperature increased—Ezetimibe—atherosclerosis	0.000806	0.00328	CcSEcCtD
Oxymorphone—Feeling abnormal—Simvastatin—atherosclerosis	0.000802	0.00326	CcSEcCtD
Oxymorphone—Dyspnoea—Niacin—atherosclerosis	0.000796	0.00324	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000795	0.00323	CcSEcCtD
Oxymorphone—Insomnia—Pravastatin—atherosclerosis	0.000795	0.00323	CcSEcCtD
Oxymorphone—Somnolence—Niacin—atherosclerosis	0.000794	0.00323	CcSEcCtD
Oxymorphone—Dyspepsia—Niacin—atherosclerosis	0.000786	0.0032	CcSEcCtD
Oxymorphone—Dyspnoea—Pravastatin—atherosclerosis	0.000784	0.00319	CcSEcCtD
Oxymorphone—Decreased appetite—Niacin—atherosclerosis	0.000776	0.00316	CcSEcCtD
Oxymorphone—Dyspepsia—Pravastatin—atherosclerosis	0.000774	0.00315	CcSEcCtD
Oxymorphone—Dermatitis—Rosuvastatin—atherosclerosis	0.000773	0.00314	CcSEcCtD
Oxymorphone—Urticaria—Simvastatin—atherosclerosis	0.000773	0.00314	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000771	0.00314	CcSEcCtD
Oxymorphone—Abdominal pain—Simvastatin—atherosclerosis	0.000769	0.00313	CcSEcCtD
Oxymorphone—Body temperature increased—Simvastatin—atherosclerosis	0.000769	0.00313	CcSEcCtD
Oxymorphone—Headache—Rosuvastatin—atherosclerosis	0.000769	0.00313	CcSEcCtD
Oxymorphone—Hypersensitivity—Lovastatin—atherosclerosis	0.000766	0.00312	CcSEcCtD
Oxymorphone—Decreased appetite—Pravastatin—atherosclerosis	0.000764	0.00311	CcSEcCtD
Oxymorphone—Pain—Niacin—atherosclerosis	0.000764	0.00311	CcSEcCtD
Oxymorphone—Fatigue—Pravastatin—atherosclerosis	0.000758	0.00308	CcSEcCtD
Oxymorphone—Constipation—Pravastatin—atherosclerosis	0.000752	0.00306	CcSEcCtD
Oxymorphone—Pain—Pravastatin—atherosclerosis	0.000752	0.00306	CcSEcCtD
Oxymorphone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000751	0.00306	CcSEcCtD
Oxymorphone—Asthenia—Lovastatin—atherosclerosis	0.000746	0.00303	CcSEcCtD
Oxymorphone—Pruritus—Lovastatin—atherosclerosis	0.000736	0.00299	CcSEcCtD
Oxymorphone—Asthenia—Ezetimibe—atherosclerosis	0.000732	0.00298	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Niacin—atherosclerosis	0.00073	0.00297	CcSEcCtD
Oxymorphone—Nausea—Rosuvastatin—atherosclerosis	0.000729	0.00296	CcSEcCtD
Oxymorphone—Feeling abnormal—Pravastatin—atherosclerosis	0.000725	0.00295	CcSEcCtD
Oxymorphone—Pruritus—Ezetimibe—atherosclerosis	0.000722	0.00293	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000719	0.00292	CcSEcCtD
Oxymorphone—Hypersensitivity—Simvastatin—atherosclerosis	0.000717	0.00291	CcSEcCtD
Oxymorphone—Diarrhoea—Lovastatin—atherosclerosis	0.000712	0.00289	CcSEcCtD
Oxymorphone—Urticaria—Niacin—atherosclerosis	0.00071	0.00289	CcSEcCtD
Oxymorphone—Abdominal pain—Niacin—atherosclerosis	0.000706	0.00287	CcSEcCtD
Oxymorphone—Body temperature increased—Niacin—atherosclerosis	0.000706	0.00287	CcSEcCtD
Oxymorphone—Urticaria—Pravastatin—atherosclerosis	0.000699	0.00284	CcSEcCtD
Oxymorphone—Asthenia—Simvastatin—atherosclerosis	0.000698	0.00284	CcSEcCtD
Oxymorphone—Diarrhoea—Ezetimibe—atherosclerosis	0.000698	0.00284	CcSEcCtD
Oxymorphone—Abdominal pain—Pravastatin—atherosclerosis	0.000695	0.00283	CcSEcCtD
Oxymorphone—Body temperature increased—Pravastatin—atherosclerosis	0.000695	0.00283	CcSEcCtD
Oxymorphone—Pruritus—Simvastatin—atherosclerosis	0.000688	0.0028	CcSEcCtD
Oxymorphone—Dizziness—Lovastatin—atherosclerosis	0.000688	0.0028	CcSEcCtD
Oxymorphone—Dizziness—Ezetimibe—atherosclerosis	0.000674	0.00274	CcSEcCtD
Oxymorphone—Diarrhoea—Simvastatin—atherosclerosis	0.000666	0.00271	CcSEcCtD
Oxymorphone—Vomiting—Lovastatin—atherosclerosis	0.000661	0.00269	CcSEcCtD
Oxymorphone—Hypersensitivity—Niacin—atherosclerosis	0.000658	0.00268	CcSEcCtD
Oxymorphone—Dermatitis—Lovastatin—atherosclerosis	0.000655	0.00266	CcSEcCtD
Oxymorphone—Headache—Lovastatin—atherosclerosis	0.000651	0.00265	CcSEcCtD
Oxymorphone—Vomiting—Ezetimibe—atherosclerosis	0.000649	0.00264	CcSEcCtD
Oxymorphone—Hypersensitivity—Pravastatin—atherosclerosis	0.000648	0.00263	CcSEcCtD
Oxymorphone—Dizziness—Simvastatin—atherosclerosis	0.000643	0.00262	CcSEcCtD
Oxymorphone—Dermatitis—Ezetimibe—atherosclerosis	0.000643	0.00261	CcSEcCtD
Oxymorphone—Asthenia—Niacin—atherosclerosis	0.000641	0.00261	CcSEcCtD
Oxymorphone—Headache—Ezetimibe—atherosclerosis	0.000639	0.0026	CcSEcCtD
Oxymorphone—Pruritus—Niacin—atherosclerosis	0.000632	0.00257	CcSEcCtD
Oxymorphone—Asthenia—Pravastatin—atherosclerosis	0.000631	0.00257	CcSEcCtD
Oxymorphone—Pruritus—Pravastatin—atherosclerosis	0.000622	0.00253	CcSEcCtD
Oxymorphone—Vomiting—Simvastatin—atherosclerosis	0.000618	0.00251	CcSEcCtD
Oxymorphone—Nausea—Lovastatin—atherosclerosis	0.000618	0.00251	CcSEcCtD
Oxymorphone—Dermatitis—Simvastatin—atherosclerosis	0.000613	0.00249	CcSEcCtD
Oxymorphone—Diarrhoea—Niacin—atherosclerosis	0.000611	0.00248	CcSEcCtD
Oxymorphone—Headache—Simvastatin—atherosclerosis	0.000609	0.00248	CcSEcCtD
Oxymorphone—Nausea—Ezetimibe—atherosclerosis	0.000606	0.00246	CcSEcCtD
Oxymorphone—Diarrhoea—Pravastatin—atherosclerosis	0.000602	0.00245	CcSEcCtD
Oxymorphone—Dizziness—Niacin—atherosclerosis	0.000591	0.0024	CcSEcCtD
Oxymorphone—Dizziness—Pravastatin—atherosclerosis	0.000582	0.00236	CcSEcCtD
Oxymorphone—Nausea—Simvastatin—atherosclerosis	0.000578	0.00235	CcSEcCtD
Oxymorphone—Vomiting—Niacin—atherosclerosis	0.000568	0.00231	CcSEcCtD
Oxymorphone—Dermatitis—Niacin—atherosclerosis	0.000563	0.00229	CcSEcCtD
Oxymorphone—Headache—Niacin—atherosclerosis	0.00056	0.00228	CcSEcCtD
Oxymorphone—Vomiting—Pravastatin—atherosclerosis	0.000559	0.00227	CcSEcCtD
Oxymorphone—Dermatitis—Pravastatin—atherosclerosis	0.000554	0.00225	CcSEcCtD
Oxymorphone—Headache—Pravastatin—atherosclerosis	0.000551	0.00224	CcSEcCtD
Oxymorphone—Nausea—Niacin—atherosclerosis	0.000531	0.00216	CcSEcCtD
Oxymorphone—Nausea—Pravastatin—atherosclerosis	0.000522	0.00212	CcSEcCtD
Oxymorphone—Naloxone—ALB—atherosclerosis	0.00052	0.0888	CrCbGaD
Oxymorphone—OPRK1—GPCR downstream signaling—F2—atherosclerosis	5.35e-05	0.000513	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	5.31e-05	0.00051	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	5.3e-05	0.000509	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AGT—atherosclerosis	5.25e-05	0.000505	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	5.19e-05	0.000498	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR2—atherosclerosis	5.19e-05	0.000498	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CYBA—atherosclerosis	5.16e-05	0.000496	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	5.12e-05	0.000491	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KNG1—atherosclerosis	5.06e-05	0.000486	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PLAT—atherosclerosis	5.06e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GHRL—atherosclerosis	5.06e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PARP1—atherosclerosis	5.06e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	5.05e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	5.03e-05	0.000483	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VWF—atherosclerosis	5.02e-05	0.000483	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOC3—atherosclerosis	4.99e-05	0.00048	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LDLR—atherosclerosis	4.96e-05	0.000477	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	4.93e-05	0.000474	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PLG—atherosclerosis	4.9e-05	0.000471	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	4.89e-05	0.00047	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—F2—atherosclerosis	4.85e-05	0.000466	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL3—atherosclerosis	4.85e-05	0.000466	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	4.65e-05	0.000446	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NCF1—atherosclerosis	4.64e-05	0.000446	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	4.64e-05	0.000446	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—F2—atherosclerosis	4.52e-05	0.000434	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP3—atherosclerosis	4.48e-05	0.000431	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.48e-05	0.00043	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF2—atherosclerosis	4.46e-05	0.000429	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AGT—atherosclerosis	4.44e-05	0.000426	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KNG1—atherosclerosis	4.44e-05	0.000426	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCG1—atherosclerosis	4.41e-05	0.000424	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	4.41e-05	0.000424	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR2—atherosclerosis	4.38e-05	0.000421	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	4.38e-05	0.000421	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CYBA—atherosclerosis	4.36e-05	0.000419	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOB—atherosclerosis	4.33e-05	0.000416	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	4.33e-05	0.000416	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	4.32e-05	0.000415	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PLG—atherosclerosis	4.3e-05	0.000413	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	4.3e-05	0.000413	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PARP1—atherosclerosis	4.27e-05	0.00041	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GHRL—atherosclerosis	4.27e-05	0.00041	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PLAT—atherosclerosis	4.27e-05	0.00041	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EDN1—atherosclerosis	4.26e-05	0.00041	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL5—atherosclerosis	4.23e-05	0.000406	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLTP—atherosclerosis	4.21e-05	0.000404	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LCAT—atherosclerosis	4.15e-05	0.000398	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—FABP4—atherosclerosis	4.15e-05	0.000398	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LPL—atherosclerosis	4.14e-05	0.000397	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—F2—atherosclerosis	4.1e-05	0.000394	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA4—atherosclerosis	4.07e-05	0.000391	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	4.07e-05	0.000391	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	4.02e-05	0.000386	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP7A1—atherosclerosis	4e-05	0.000384	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP3—atherosclerosis	3.93e-05	0.000378	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	3.93e-05	0.000377	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SPP1—atherosclerosis	3.92e-05	0.000376	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF2—atherosclerosis	3.91e-05	0.000376	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	3.9e-05	0.000375	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOB—atherosclerosis	3.8e-05	0.000365	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	3.77e-05	0.000362	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KNG1—atherosclerosis	3.75e-05	0.00036	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDN1—atherosclerosis	3.74e-05	0.000359	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	3.73e-05	0.000358	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL5—atherosclerosis	3.71e-05	0.000356	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.7e-05	0.000355	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	3.66e-05	0.000351	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.65e-05	0.00035	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.65e-05	0.00035	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PLG—atherosclerosis	3.63e-05	0.000349	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LPL—atherosclerosis	3.63e-05	0.000348	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	3.63e-05	0.000348	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGT—atherosclerosis	3.54e-05	0.00034	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	3.53e-05	0.000339	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.51e-05	0.000337	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.51e-05	0.000337	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.51e-05	0.000337	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA2—atherosclerosis	3.51e-05	0.000337	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LEP—atherosclerosis	3.47e-05	0.000333	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOE—atherosclerosis	3.47e-05	0.000333	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.46e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	3.44e-05	0.00033	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SPP1—atherosclerosis	3.44e-05	0.00033	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CAV1—atherosclerosis	3.44e-05	0.00033	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APOA1—atherosclerosis	3.43e-05	0.000329	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	3.42e-05	0.000329	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LPA—atherosclerosis	3.34e-05	0.000321	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP3—atherosclerosis	3.32e-05	0.000319	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ESR1—atherosclerosis	3.31e-05	0.000318	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF2—atherosclerosis	3.31e-05	0.000318	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—F2—atherosclerosis	3.27e-05	0.000314	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—BGN—atherosclerosis	3.24e-05	0.000311	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOB—atherosclerosis	3.21e-05	0.000308	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA5—atherosclerosis	3.21e-05	0.000308	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	3.18e-05	0.000306	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	3.18e-05	0.000305	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDN1—atherosclerosis	3.16e-05	0.000303	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL5—atherosclerosis	3.14e-05	0.000301	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	3.13e-05	0.000301	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGT—atherosclerosis	3.1e-05	0.000298	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.09e-05	0.000296	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LPL—atherosclerosis	3.07e-05	0.000294	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LEP—atherosclerosis	3.04e-05	0.000292	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOE—atherosclerosis	3.04e-05	0.000292	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CAV1—atherosclerosis	3.01e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOA1—atherosclerosis	3.01e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	3e-05	0.000288	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	2.98e-05	0.000286	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.98e-05	0.000286	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—INS—atherosclerosis	2.96e-05	0.000285	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL2—atherosclerosis	2.92e-05	0.00028	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SPP1—atherosclerosis	2.9e-05	0.000279	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—atherosclerosis	2.9e-05	0.000279	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	2.89e-05	0.000278	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.88e-05	0.000277	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—F2—atherosclerosis	2.87e-05	0.000275	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1—atherosclerosis	2.87e-05	0.000275	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	2.74e-05	0.000264	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	2.72e-05	0.000261	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FABP4—atherosclerosis	2.71e-05	0.00026	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LCAT—atherosclerosis	2.71e-05	0.00026	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	2.69e-05	0.000258	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.67e-05	0.000257	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA4—atherosclerosis	2.66e-05	0.000256	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LIPC—atherosclerosis	2.66e-05	0.000255	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOC3—atherosclerosis	2.64e-05	0.000254	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	2.63e-05	0.000252	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LDLR—atherosclerosis	2.62e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGT—atherosclerosis	2.62e-05	0.000252	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.62e-05	0.000251	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—atherosclerosis	2.6e-05	0.00025	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—INS—atherosclerosis	2.6e-05	0.000249	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOE—atherosclerosis	2.57e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—atherosclerosis	2.57e-05	0.000247	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CETP—atherosclerosis	2.56e-05	0.000246	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL2—atherosclerosis	2.56e-05	0.000245	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CAV1—atherosclerosis	2.55e-05	0.000245	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOA1—atherosclerosis	2.54e-05	0.000244	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—atherosclerosis	2.51e-05	0.000241	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.45e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—atherosclerosis	2.45e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—F2—atherosclerosis	2.42e-05	0.000233	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.42e-05	0.000232	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	2.39e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	2.32e-05	0.000223	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.32e-05	0.000223	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	2.3e-05	0.000221	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.29e-05	0.00022	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA2—atherosclerosis	2.29e-05	0.00022	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.29e-05	0.00022	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.29e-05	0.00022	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—atherosclerosis	2.28e-05	0.000219	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.26e-05	0.000217	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	2.23e-05	0.000214	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	2.22e-05	0.000213	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—INS—atherosclerosis	2.2e-05	0.000211	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—atherosclerosis	2.19e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LPA—atherosclerosis	2.19e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL2—atherosclerosis	2.16e-05	0.000207	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—atherosclerosis	2.12e-05	0.000204	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BGN—atherosclerosis	2.12e-05	0.000203	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA5—atherosclerosis	2.1e-05	0.000201	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—atherosclerosis	2.08e-05	0.0002	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.07e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	2.06e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	2.03e-05	0.000195	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	2.02e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	2.02e-05	0.000194	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.02e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	2.02e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	1.95e-05	0.000187	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.95e-05	0.000187	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—atherosclerosis	1.93e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—atherosclerosis	1.92e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	1.87e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—atherosclerosis	1.85e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—atherosclerosis	1.83e-05	0.000176	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	1.81e-05	0.000174	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	1.78e-05	0.000171	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	1.77e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.77e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	1.77e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.75e-05	0.000168	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.74e-05	0.000167	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.73e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	1.72e-05	0.000165	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.72e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	1.71e-05	0.000164	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOB—atherosclerosis	1.7e-05	0.000163	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CETP—atherosclerosis	1.68e-05	0.000161	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.65e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.65e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	1.64e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—atherosclerosis	1.63e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—atherosclerosis	1.62e-05	0.000156	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—LPL—atherosclerosis	1.62e-05	0.000156	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.6e-05	0.000154	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX1—atherosclerosis	1.58e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	1.55e-05	0.000149	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—atherosclerosis	1.54e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD36—atherosclerosis	1.54e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	1.53e-05	0.000147	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.52e-05	0.000146	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	1.51e-05	0.000145	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	1.5e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	1.5e-05	0.000144	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.00014	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARA—atherosclerosis	1.43e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	1.39e-05	0.000133	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AGT—atherosclerosis	1.39e-05	0.000133	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—atherosclerosis	1.37e-05	0.000132	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOE—atherosclerosis	1.36e-05	0.00013	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.35e-05	0.00013	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CAV1—atherosclerosis	1.35e-05	0.000129	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA1—atherosclerosis	1.34e-05	0.000129	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	1.31e-05	0.000126	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—atherosclerosis	1.29e-05	0.000124	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	1.27e-05	0.000122	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.23e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—atherosclerosis	1.19e-05	0.000115	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—atherosclerosis	1.18e-05	0.000114	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—INS—atherosclerosis	1.16e-05	0.000111	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.16e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOB—atherosclerosis	1.11e-05	0.000107	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.08e-05	0.000104	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—atherosclerosis	1.06e-05	0.000102	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LPL—atherosclerosis	1.06e-05	0.000102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—atherosclerosis	1.05e-05	0.000101	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX1—atherosclerosis	1.03e-05	9.93e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—atherosclerosis	1.02e-05	9.78e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD36—atherosclerosis	1.01e-05	9.67e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—atherosclerosis	9.59e-06	9.21e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—atherosclerosis	9.54e-06	9.16e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARA—atherosclerosis	9.36e-06	8.99e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—atherosclerosis	9.31e-06	8.94e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AGT—atherosclerosis	9.07e-06	8.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOE—atherosclerosis	8.88e-06	8.53e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—atherosclerosis	8.85e-06	8.5e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CAV1—atherosclerosis	8.8e-06	8.45e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA1—atherosclerosis	8.78e-06	8.43e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.02e-06	7.7e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—atherosclerosis	7.74e-06	7.43e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—INS—atherosclerosis	7.59e-06	7.29e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—atherosclerosis	6.96e-06	6.68e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—atherosclerosis	6.66e-06	6.39e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.09e-06	5.85e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—atherosclerosis	4.68e-06	4.49e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—atherosclerosis	3.06e-06	2.94e-05	CbGpPWpGaD
